Liposomes for Targeted Delivery of Active Agents against Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease)

<table>The antibodies of the immunoliposomes recognise the specific receptor of the BBB releasing the drug of the immunoliposomes only close to the targeting cells.</table>

Journal of Drug Delivery

fig2

Figure 2

Figure 2: Liposomes for Targeted Delivery of Active Agents against Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease) 